MCR American Pharmaceuticals is a specialty pharmaceutical company that focuses on the marketing, development, sales and distribution of the highest quality pharmaceuticals. The company explains below its 12 cold-fighting medications that work to relieve the common cold.

Brooksville, Florida — May 21, 2012

The company recently debuted a new product line of cold fighting medications, the new products are congestion relieving medications and they include Congestinex, Congestinex C, Congestinex DM and Congestinex PE.

Congestinex is an expectorant that relieves the common cold and is available in cherry flavor. MCR American Pharmaceuticals explains that such a product helps loosen phlegm and thin bronchial secretions to relieve coughs. Furthermore, it helps relieve a stuffed-up nose caused by a cold virus or the flu, sinusitis, or allergies.

The Congestinex C medication is an antihistamine, available in grape flavor and is recommended for patients who have post-nasal drip cough. Congestinex C can help calm a runny nose and may stop sneezing. MCR American Pharmaceuticals explains that Congestinex C is different from most cold fighting medications in that it is safe for ages two and older. MCR American Pharmaceuticals designed Congestinex C to suit young children by using lower doses of Chlorpheniramine, and Dextromethorphan.

MCR American Pharmaceuticals launched Congestinex DM several weeks ago and it is a antitussive and expectorant that arrives in cherry flavor. The medication treats a dry, irritated cough caused by the flu or common cold. MCR American Pharmaceuticals explains that Congestinex DM is used in the treatment of coughs to help expel exudates and secretions. Congestion DM loosens the mucus in the lungs and releases a low dose narcotic cough suppressant that works directly on the brain to decrease the urge to cough.

The last item in the Congestinex product group is Congestinex PE. MCR American Pharmaceuticals explains the medication is an expectorant, antitussive and decongestant that relieves symptoms due to a common cold, hay fever or other respiratory allergies. MCR American Pharmaceuticals explains the benefits to such medication is the low dose of Dextromethorphan, Guaifenesin, and Phenylepherine. The low dosage of such ingredients ensures the medication is suitable for young ages and is safe to consume.

The next medication group that MCR American Pharmaceuticals manufactures is the Maxiphen product family that includes Maxiphen and Maxiphen DM. MCR American Pharmaceuticals explains that Maxiphen is an expectorant and decongestant that contains Phenylephrine and Guaifenesin. Maxiphen helps patients who have congestion due to the common cold, sinusitis, hay fever, and allergic rhinitis.

The Maxiphen DM product is an expectorant, decongestant and suppressant that contains Phenylephrine, Guaifenesin, and Dextromethorphan. Maxiphen DM helps patients who have congestion due to the common cold, sinusitis, hay fever, and allergic rhinitis.

Another medication group manufactured by MCR American Pharmaceuticals is Maxifed. The Maxifed product family consists of Maxifed, Maxifed DMX, Maxifed G, and Maxifed DM. MCR American Pharmaceuticals explains that all four products are good for the common cold, hay fever, and allergic rhinitis.

Maxifed is a decongestant and expectorant combination that contains Pseudoephedrine and Guaifenesin. Maxifed DMX is a decongestant, expectorant and cough suppressant combination that contains Pseudoephedrine, Guaifenesin, and Dextromethorphan. MCR American Pharmaceuticals recommends Maxifed DMX for those who suffer from post nasal drip cough.

The MCR American Pharmaceuticals Maxifed G product is a decongestant and expectorant combination that contains Pseudoephedrine and Guaifenesin and is recommended in fighting the common cold, sinusitis, hay fever, and allergic rhinitis. The final medication in the Maxifed product family is Maxifed DM, an expectorant, decongestant, and suppressant that contains Pseudoephedrine, Guaifenesin, and Dextromethorphan and is strong enough to cure post nasal drip cough.

Lastly, MCR American Pharmaceuticals manufactured Super-Tuss, a medication group that consists of Super-Tuss PE and Super-Tuss PSE. MCR American Pharmaceuticals explains that Super-Tuss PE comes in an AM dose form and a PM dose form. The AM dose is a cough suppressant, expectorant and nasal decongestant combination that contains Dextromethorphan, Guaifenesin, and Phenylephrine. The PM dose is a antihistamine and cough suppressant combination that contains Chlorpheniramine and Dextromethorphan. Both dose forms are ideal in fighting the common cold, sinusitis, hay fever, and allergic rhinitis.

Super-Tuss PSE also arrives in an AM and PM dose form. The AM dose is a cough suppressant, expectorant, and decongestant combination that contains Dextromethorphan, Guaifenesin, and Pseudoephedrine. The PM dose is a antihistamine and cough suppressant combination that contains Chlorpheniramine and Dextromethorphan. Both dose forms are ideal in fighting the common cold, sinusitis, hay fever, and allergic rhinitis.

In conclusion, MCR American Pharmaceuticals offers a variety of medications that all serve to fight the common cold, sinusitis, hay fever, and allergic rhinitis. The medications include four product families called Congestinex, Maxifed, Maxiphen and Super-Tuss. The Congestinex product family consists of Congestinex, Congestinex C, Congestinex DM and Congestinex PE. Maxifed consists of Maxifed, Maxifed DMX, Maxifed G, and Maxifed DM. Maxiphen consists of Maxiphen and Maxiphen DM. And lastly, the Super-Tuss product family consists of Super-Tuss PE and Super-Tuss PSE. MCR American Pharmaceuticals manufactured these products to help benefit everyone who feels a bit under the weather. All the company's products are sold directly on the company's Web site.

More About MCR American Pharmaceuticals

Brooksville-based specialty pharmaceutical company MCR American Pharmaceuticals is focused on the marketing and development of the highest quality pharmaceuticals. MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL. and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by Dave Ambrose and was relocated to Brooksville, FL. and in 2008 the company was acquired by Neuro-HiTech. Today MCR American Pharmaceuticals’ products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.

For additional information, interview and image requests contact Virtuos Online.